KORIO
28 employees
Biotech/Pharma
Series A · $12.3M
Open positions (1)
Company details
Team Size28
IndustryBiotech/Pharma
Funding
Total raised
$12.3M
Last stage
Series A
Investors
Boston Millennia Partners
Total raised
$12.3M
Last stage
Series A
Investors
Ryan Keane
Co-Founder and CEO of Korio, Inc. Previously served as Chief Commercial Officer at Endpoint Clinical. Brings extensive experience in the IRT/RTSM space.
LinkedInChuck Harris
Co-Founder and COO of Korio, Inc. Together with Ryan Keane, brings a combined 30+ years of experience in the IRT space, including scaling a previous IRT startup to a leading global provider.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.